We are live on
!
Find out more
CC
ClearArc Capital Portfolio holdings
AUM
$257M
1-Year Est. Return
33.81%
This Fund
S&P 500
This Quarter
Est. Return
+5.52%
1 Year Est. Return
+33.81%
3 Year Est. Return
+63.41%
5 Year Est. Return
+95.17%
10 Year Est. Return
–
AUM
$434M
AUM Growth
+$29.2M
(+7.2%)
Cap. Flow
+$11.3M
Cap. Flow
% of AUM
2.61%
Top 10 Holdings %
Top 10 Hldgs %
16.68%
Holding
407
New
26
Increased
249
Reduced
113
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.08M |
| 2 |
SVC
Service Properties Trust
SVC
|
+$1.9M |
| 3 |
PPL
PPL Corp
PPL
|
+$1.79M |
| 4 |
Camden Property Trust
CPT
|
+$1.59M |
| 5 |
DRE
Duke Realty Corp.
DRE
|
+$1.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.55M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.1M |
| 3 |
BP
BP
|
+$798K |
| 4 |
Xerox
XRX
|
+$774K |
| 5 |
AstraZeneca
AZN
|
+$716K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.83% |
| 2 | Technology | 14.13% |
| 3 | Healthcare | 12.38% |
| 4 | Energy | 11.6% |
| 5 | Industrials | 10.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Carnival Corporation Ltd
CCL
$39.7B
| $332K | 0.08% |
8,819
+155
| +2% | +$6K |
|
277
Moody's
MCO
$82.7B
| $331K | 0.08% |
3,779
+42
| +1% | +$3.46K |
|
278
M&T Bank
MTB
$36.2B
| $330K | 0.08% |
2,659
+79
| +3% | +$9.63K |
|
279
Brown-Forman Class B
BF.B
$13.1B
| $329K | 0.08% |
10,922
+400
| +4% | +$11.7K |
|
280
EQT Corp
EQT
$32.3B
| $326K | 0.08% |
5,594
+125
| +2% | +$7.17K |
|
281
Xcel Energy
XEL
$48.8B
| $326K | 0.08% |
10,112
+257
| +3% | +$7.96K |
|
282
BorgWarner
BWA
$13.9B
| $325K | 0.07% |
5,663
-911
| -14% | -$50.2K |
|
283
Warner Bros
WBD
$67.1B
| $325K | 0.07% |
8,570
-39
| -0.5% | -$1.53K |
|
284
Zoetis
ZTS
$30B
| $325K | 0.07% |
10,079
+192
| +2% | +$5.89K |
|
|
SWN
285
DELISTED
Southwestern Energy Company
SWN
| $323K | 0.07% |
7,103
+125
| +2% | +$5.79K |
|
|
FISV
286
Fiserv Inc
FISV
$27.9B
| $322K | 0.07% |
10,688
-3,152
| -23% | -$93.4K |
|
287
The Mosaic Company
MOS
$7.33B
| $322K | 0.07% |
6,521
-193
| -3% | -$9.51K |
|
288
O'Reilly Automotive
ORLY
$76.3B
| $322K | 0.07% |
32,040
+315
| +1% | +$3.11K |
|
289
Capri Holdings
CPRI
$1.74B
| $320K | 0.07% |
3,606
-4
| -0.1% | -$367 |
|
290
Gen Digital
GEN
$17.5B
| $319K | 0.07% |
13,929
+239
| +2% | +$5.08K |
|
|
GMCR
291
DELISTED
KEURIG GREEN MTN INC
GMCR
| $318K | 0.07% |
2,555
+9
| +0.4% | +$982 |
|
292
Intuitive Surgical
ISRG
$134B
| $317K | 0.07% |
6,939
+90
| +1% | +$3.97K |
|
|
CHK
293
DELISTED
Chesapeake Energy Corporation
CHK
| $317K | 0.07% |
54
+1
| +2% | +$5.45K |
|
294
Fidelity National Information Services
FIS
$22.1B
| $316K | 0.07% |
5,777
+23
| +0.4% | +$1.23K |
|
295
Nucor
NUE
$62.1B
| $315K | 0.07% |
6,404
+88
| +1% | +$4.52K |
|
296
Trane Technologies
TT
$106B
| $315K | 0.07% |
5,040
-86
| -2% | -$5.11K |
|
297
W.W. Grainger
GWW
$60.2B
| $311K | 0.07% |
1,224
+1
| +0.1% | +$255 |
|
|
HOT
298
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
| $311K | 0.07% |
3,850
+48
| +1% | +$3.77K |
|
299
Transocean
RIG
$5.82B
| $309K | 0.07% |
6,858
+144
| +2% | +$6.13K |
|
300
Harley-Davidson
HOG
$2.71B
| $308K | 0.07% |
4,408
+44
| +1% | +$3.1K |
|
Similar funds
BO
GCA
QCM
AEPI
AC
LA
JFM
SHA
ClearArc Capital's Q2 2014 Portfolio in Review
As of Q2 2014, ClearArc Capital held 407 positions worth $434M, up 7.2% from $405M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
ClearArc Capital's Q2 2014 filing shows 26 new, 249 increased, 113 reduced and 16 closed positions. Its largest new stake was Service Properties Trust: 12,988 shares worth $1.96M. The largest sale was Pfizer, an estimated $1.55M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- ClearArc Capital's largest Q2 2014 buy was Service Properties Trust: 12,988 shares worth $1.96M.
- ClearArc Capital added most to SLB Ltd in Q2 2014, an estimated $2.08M increase.
- ClearArc Capital's biggest Q2 2014 reduction was Pfizer, cutting an estimated $1.55M.
- ClearArc Capital fully exited AstraZeneca in Q2 2014, selling an estimated $716K.
- ClearArc Capital's ten largest holdings make up 17% of its $434M portfolio in Q2 2014.
- ClearArc Capital opened 26 new positions and closed 16 in Q2 2014.
- ClearArc Capital's portfolio value rose 7.2% quarter-over-quarter to $434M.
Based on ClearArc Capital's 13F filing for Q2 2014, filed 14 Aug 2014.